文献速递心脑血管急症创伤与烧伤重症综合管理与镇静镇痛

未达满分昏迷量表的深远影响:评估轻度硬膜下出血患者中GCS 13-14分与15分的结局差异

Nuance and profound impact: Evaluating the effects of the unmet full coma scale in patients with mild subdural hemorrhage.
PubMed 文献 · Am J Emerg Med · 2023-12-04
一句话结论轻度硬膜下出血且GCS 13-14分者,神经功能恶化、手术干预及不良预后均显著高于GCS 15分者。

该回顾性研究纳入2019年1月1日至2020年12月31日期间GCS 13-15分的硬膜下出血患者470例,比较GCS 15分(N=375)与GCS 13-14分(N=95)两组的结局。GCS 13-14组神经功能恶化率(33.7% vs. 10.4%,p<0.001)和神经外科干预率(26.3% vs. 16.3%,p=0.024)显著更高,死亡率(7.4% vs. 2.4%,p=0.017)、出院时意识障碍率(21.1% vs. 4.0%,p<0.001)及神经功能障碍率(29.5% vs. 6.9%,p<0.001)均更差。多因素logistic回归显示,在GCS 15分患者中,硬膜下血肿厚度是出院时神经功能障碍的独立危险因素(OR=1.127,p=0.006)。作者认为,GCS 13-14分的轻度TBI硬膜下出血患者神经结局较GCS 15分者更差,血肿厚度与GCS 15分患者的神经功能障碍正相关。

要点

  • GCS 13-14分的硬膜下出血患者神经功能恶化率33.7%,显著高于GCS 15分者的10.4%(p<0.001)。
  • GCS 13-14分者神经外科干预率26.3%,高于GCS 15分者的16.3%(p=0.024)。
  • GCS 13-14分者死亡率7.4% vs. GCS 15分者2.4%(p=0.017),出院时意识障碍率21.1% vs. 4.0%(p<0.001)。
  • GCS 13-14分者出院时神经功能障碍率29.5%,高于GCS 15分者的6.9%(p<0.001)。
  • GCS 15分的硬膜下出血患者中,血肿厚度是出院时神经功能障碍的独立危险因素(OR=1.127,p=0.006)。

适用人群与场景

  • 2019年1月1日至2020年12月31日期间收治的硬膜下出血(SDH)且GCS评分13-15分的患者,共470例;GCS 15分组N=375,GCS 13-14分组N=95。

诊断标准与关键阈值

  • GCS评分13-15分被归类为轻度创伤性脑损伤;GCS 15分为满分(最大GCS评分),GCS 13-14分为未达满分。

红旗征与不能漏的情况

  • GCS 13-14分的硬膜下出血患者神经功能恶化率33.7%、神经外科干预率26.3%,需警惕病情恶化及手术需求。
  • GCS 13-14分者死亡率7.4%、出院时意识障碍率21.1%、出院时神经功能障碍率29.5%,均显著高于GCS 15分者。

研究设计与关键结果

  • 回顾性研究,纳入470例GCS 13-15分的硬膜下出血患者,比较GCS 15分(N=375)与GCS 13-14分(N=95)两组的结局。
  • GCS 13-14组 vs. GCS 15分组:神经功能恶化率33.7% vs. 10.4%(p<0.001);神经外科干预率26.3% vs. 16.3%(p=0.024)。
  • GCS 13-14组 vs. GCS 15分组:死亡率7.4% vs. 2.4%(p=0.017);出院时意识障碍率21.1% vs. 4.0%(p<0.001);出院时神经功能障碍率29.5% vs. 6.9%(p<0.001)。
  • 多因素logistic回归分析显示,在GCS 15分患者中,硬膜下血肿厚度是出院时神经功能障碍的独立危险因素(OR=1.127,p=0.006)。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在轻度创伤性脑损伤的硬膜下出血患者中,GCS 13-14分者神经结局较GCS 15分者更差。
  • 作者认为,硬膜下血肿厚度与GCS 15分硬膜下出血患者的神经功能障碍正相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Patients with subdural hemorrhage (SDH) and a Glasgow Coma Scale (GCS) score of 13-15 are typically categorized as having mild traumatic brain injury. We hypothesize that patients without a maximum GCS score - specifically, patients with GCS scores of 13 and 14 - may exhibit poorer neurological outcomes.

METHOD: Between January 1, 2019, and December 31, 2020, SDH patients with GCS scores ranging from 13 to 15 were retrospectively studied. We compared outcomes between patients with a maximum GCS score of 15 and those with scores of either 13 or 14. Independent factors associated with neurological deterioration among patients with a GCS score of 15 were evaluated using multivariate logistic regression (MLR) analysis.

RESULTS: During the study period, 470 patients with SDH and GCS scores between 13 and 15 were examined. Compared to patients with a maximum GCS score (N = 375), those in the GCS 13-14 group (N = 95) showed significantly higher rates of neurological deterioration (33.7% vs. 10.4%, p value <0.001) and neurosurgical interventions (26.3% vs. 16.3%, p value <0.024). Moreover, the GCS 13-14 group had a significantly poorer prognosis than patients with a GCS score of 15 [mortality rate: 7.4% vs. 2.4%, p value <0.017; rate of impaired consciousness at discharge: 21.1% vs. 4.0%, p value <0.001; and rate of neurological disability at discharge: 29.5% vs. 6.9%, p value <0.001]. The MLR analysis revealed that SDH thickness (odds ratio = 1.127, p value = 0.006) was an independent risk factor for neurological disability at discharge in patients with a GCS score of 15.

CONCLUSION: Among SDH patients with mild TBI, those with GCS scores of 13-14 exhibited poorer neurological outcomes than those with a maximum GCS score. The thickness of the SDH is positively associated with neurological disability in SDH patients with a maximum GCS score.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Chien SC, Kang SC, Tu PH, et al. Nuance and profound impact: Evaluating the effects of the unmet full coma scale in patients with mild subdural hemorrhage. Am J Emerg Med. 2023. PMID: 38103392. doi:10.1016/j.ajem.2023.11.038

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。